Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Special Income (Charges) | -$8,000.00 | -$5,000.00 | $31,000.00 | -$7,000.00 | -$108,000.00 |
| Depreciation & Amortization & Depletion | $645,000.00 | $2.05M | – | – | $466,000.00 |
| Research & Development | $2.69M | $2.36M | $2.62M | $2.53M | $3.18M |
| -General & Admin Expense | $32.30M | $19.91M | $22.58M | $18.91M | $24.43M |
| -Selling & Marketing Expense | $20.76M | $18.78M | $17.56M | $15.27M | $12.84M |
| Selling and Admin Expenses | $53.06M | $38.69M | $40.14M | $34.18M | $37.27M |
| Operating Expense | $58.04M | $43.36M | $42.95M | $36.48M | $40.99M |
| Gross Profit | $105.56M | $85.85M | $82.95M | $77.05M | $76.94M |
| Cost of Revenue | $306.09M | $273.64M | $279.80M | $255.59M | $245.66M |
| Total Operating Revenue | $411.64M | $359.49M | $362.75M | $332.64M | $322.61M |
| Total Revenue as Reported | $411.64M | $359.49M | $362.75M | $332.64M | $322.61M |
| Gain on Sale of Security | -$847,000.00 | -$280,000.00 | -$707,000.00 | -$557,000.00 | $647,000.00 |
| Tax | $7.57M | $7.79M | $5.20M | $6.86M | $6.40M |
| Asset Impairment Loss | $1.64M | $272,000.00 | -$70,000.00 | -$192,000.00 | $69,000.00 |
| Operating Profit | $47.52M | $42.48M | $40.00M | $40.57M | $35.95M |
| -Gain on Sale of Property/Plant/Equipment | -$8,000.00 | -$5,000.00 | $31,000.00 | -$7,000.00 | -$108,000.00 |
| Other Non-Operating Income (Expenses) | $293,000.00 | $854,000.00 | $1.27M | $980,000.00 | $1.68M |
| Pretax Profit | $49.91M | $45.92M | $43.70M | $44.03M | $40.95M |
| Other Income (Expense) | -$562,000.00 | $569,000.00 | $598,000.00 | $416,000.00 | $2.22M |
| Net Profit | $42.34M | $38.12M | $38.50M | $37.18M | $34.55M |
| Profit from Continuing Operations | $42.34M | $38.12M | $38.50M | $37.18M | $34.55M |
| Net Income to Parent Company | $42.34M | $38.12M | $38.50M | $37.18M | $34.55M |
| Net Income to Common Stockholders | $42.34M | $38.12M | $38.50M | $37.18M | $34.55M |
| Basic EPS | $1.16 | $1.04 | $1.04 | $0.99 | $0.91 |
| Diluted EPS | $1.16 | $1.04 | $1.04 | $0.99 | $0.91 |
| Non-Operating Interest Expense | $106,000.00 | $120,000.00 | $74,000.00 | $71,000.00 | $32,000.00 |
| Non-Operating Interest Income | $3.06M | $2.98M | $3.17M | $3.12M | $2.81M |
| Net Non-Operating Interest Income (Expense) | $2.95M | $2.86M | $3.10M | $3.05M | $2.78M |
| -Depreciation & Amortization | $645,000.00 | $2.05M | – | – | $466,000.00 |
| Other Operating Expenses | – | – | – | -$40,000.00 | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| Free Cash Flow | $45.12M | -$26.20M | $61.66M | $182.79M | $77.06M |
| Net cash flow from investing | -$14.19M | -$14.81M | -$8.65M | -$5.09M | $27.74M |
| -Change in Payables and Accrued Expense | -$8.87M | -$10.93M | $40.54M | $56.62M | $23.03M |
| -Change in Prepaid Assets | -$21.93M | -$128,000.00 | -$227,000.00 | -$5.23M | -$5.03M |
| -Change in Inventory | $20.72M | -$43.46M | -$12.28M | -$11.52M | $9.69M |
| -Change in Receivables | -$9.09M | -$10.16M | -$5.74M | -$5.77M | $9.66M |
| Change in Working Capital | -$20.71M | -$65.13M | $21.63M | $32.87M | $36.69M |
| Other Non-Cash Items | $14.35M | $1.71M | $1.86M | $7.13M | $1.92M |
| Depreciation & Depletion & Amortization | $2.21M | $2.23M | $2.03M | $8.33M | $2.12M |
| Net Income from Continuing Operations | $42.34M | $38.12M | $38.50M | $137.37M | $37.18M |
| Net cash flow from continuing operations | $48.44M | -$21.74M | $64.37M | $190.66M | $78.25M |
| Operating Cash Flow | $48.44M | -$21.74M | $64.37M | $190.66M | $78.25M |
| -Change In Other Working Capital | -$1.54M | -$459,000.00 | -$668,000.00 | -$1.23M | -$663,000.00 |
| Effect of Exchange Rate Changes | $132,000.00 | -$546,000.00 | -$608,000.00 | $2.31M | $204,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$14.19M | -$14.81M | -$8.65M | -$5.09M | $27.74M |
| Beginning Cash Balance | $331.04M | $380.54M | $335.55M | $260.44M | $240.81M |
| Net Change in Cash | $4.07M | -$48.96M | $45.59M | $117.79M | $94.54M |
| Ending Cash Balance | $335.24M | $331.04M | $380.54M | $380.54M | $335.55M |
| Net Common Stock Issuance | -$30.03M | -$12.27M | -$10.03M | -$67.40M | -$11.34M |
| Net Issuance Payments Of Debt | -$152,000.00 | -$148,000.00 | -$93,000.00 | -$377,000.00 | -$106,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$30.18M | -$12.42M | -$10.12M | -$67.78M | -$11.45M |
| Financing Cash Flow | -$30.18M | -$12.42M | -$10.12M | -$67.78M | -$11.45M |
| Net Investment Purchase and Sale | -$10.00M | $2.97M | -$5.00M | $3.59M | $28.91M |
| Net Business Purchase and Sale | -$955,000.00 | -$13.33M | – | -$1.00M | – |
| Net PPE Purchase and Sale | -$3.23M | -$4.45M | -$2.65M | -$7.68M | -$1.17M |
| Gain/Loss from Continuing Operations | – | $992,000.00 | – | – | – |
No comments yet — be the first to weigh in on GCT.